Skip to main content
AHN-GOOK PHARMACEUTICAL Co., Ltd. logo

AHN-GOOK PHARMACEUTICAL Co., Ltd. — Investor Relations & Filings

Ticker · 001540 ISIN · KR7001540004 KO Manufacturing
Filings indexed 170 across all filing types
Latest filing 2025-10-16 Regulatory Filings
Country KR South Korea
Listing KO 001540

About AHN-GOOK PHARMACEUTICAL Co., Ltd.

https://www.no1health2.or.kr:19621/

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Recent filings

Filing Released Lang Actions
주주총회소집결의 (임시주주총회)
Regulatory Filings
2025-10-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2025-10-16 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for Ahn-Gook Pharmaceutical Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial data, business operations, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and major contracts (such as collateral agreements) of a major shareholder (the CEO of Ahn-Gook Pharmaceutical). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and major contracts (such as collateral agreements) of a major shareholder and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-05 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Ahn-Gook Pharmaceutical Co., Ltd. for the period of January 1, 2025, to March 31, 2025. It contains detailed financial statements, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.